American Portfolios Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

American Portfolios Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$9.61K	Hold	400	–	–	﹤0.01%	2547
2022 Q2	$7.7K	Hold	400	–	–	﹤0.01%	2671
2022 Q1	$6.95K	Hold	400	–	–	﹤0.01%	2834
2021 Q4	$8.76K	Hold	400	–	–	﹤0.01%	2674
2021 Q3	$7.64K	Hold	400	–	–	﹤0.01%	2677
2021 Q2	$6.87K	Hold	400	–	–	﹤0.01%	2680
2021 Q1	$8.94K	Buy	+400	New	+$9.04K	﹤0.01%	2432
2020 Q4	–	Sell	-400	Closed	-$5.9K	–	3092
2020 Q3	$5.9K	Hold	400	–	–	﹤0.01%	2207
2020 Q2	$5.93K	Buy	+400	New	+$6.09K	﹤0.01%	2170

Other funds holding SNDX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

American Portfolios Advisors's SNDX Position: Q3 2022 in Review

American Portfolios Advisors held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2022 at 400 shares worth $9.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

American Portfolios Advisors first reported a position in SNDX in Q2 2020 and has held it in 9 quarters since. 139 funds tracked by Wall St. Rank hold SNDX as of Q3 2022.

American Portfolios Advisors held 400 shares of Syndax Pharmaceuticals worth $9.61K as of Q3 2022.
American Portfolios Advisors left its Syndax Pharmaceuticals share count unchanged in Q3 2022.
Syndax Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2547 holding.
American Portfolios Advisors first reported a position in Syndax Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
139 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.